Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0N2KU
|
|||
Former ID |
DNC009881
|
|||
Drug Name |
PF-3409409
|
|||
Synonyms |
CHEMBL552338; PF-3409409; SCHEMBL5888234; BDBM50297077
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Attention deficit hyperactivity disorder [ICD-11: 6A05.Z; ICD-9: 314] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C17H21F3N2O
|
|||
Canonical SMILES |
C1CC(C1)CN(C2CCNC2)C(=O)C3=CC=CC=C3C(F)(F)F
|
|||
InChI |
1S/C17H21F3N2O/c18-17(19,20)15-7-2-1-6-14(15)16(23)22(11-12-4-3-5-12)13-8-9-21-10-13/h1-2,6-7,12-13,21H,3-5,8-11H2/t13-/m0/s1
|
|||
InChIKey |
SWADTMSKMJUFBO-ZDUSSCGKSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more po... Bioorg Med Chem Lett. 2009 Aug 15;19(16):4579-83. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.